Henan Taloph Pharmaceutical Stock Co Ltd Total Liabilities
Henan Taloph Pharmaceutical Stock Co Ltd total liabilities. Based on the latest financial reports, Henan Taloph Pharmaceutical Stock Co Ltd (600222) has total liabilities worth CN¥2.01 Billion CNY (≈ $294.28 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Henan Taloph Pharmaceutical Stock Co Ltd liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Henan Taloph Pharmaceutical Stock Co Ltd (1996–2025)
Total liabilities of Henan Taloph Pharmaceutical Stock Co Ltd from 1996 to 2025. This chart illustrates how Henan Taloph Pharmaceutical Stock Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore 600222 strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Henan Taloph Pharmaceutical Stock Co Ltd Competitors by Total Liabilities
The table below lists competitors of Henan Taloph Pharmaceutical Stock Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Visco Vision Inc.
TW:6782
|
Taiwan | NT$1.84 Billion |
|
Changzhou Almaden Co Ltd
SHE:002623
|
China | CN¥2.88 Billion |
|
LG Chem Ltd
KO:051915
|
Korea | ₩52.25 Trillion |
|
Fujian Yongfu Power Engineering Co Ltd Class A
SHE:300712
|
China | CN¥2.38 Billion |
|
SAPPI LTD ADR/1 RC 1
F:SPIA
|
Germany | €3.65 Billion |
|
ShaoYang Victor Hydraulics Co.Ltd
SHE:301079
|
China | CN¥392.60 Million |
|
Zhangjiagang Guangda Special Material Co Ltd
SHG:688186
|
China | CN¥7.41 Billion |
|
Universal Health Realty Income Trust
NYSE:UHT
|
USA | $423.21 Million |
Liability Composition Analysis (1996–2025)
This chart breaks down Henan Taloph Pharmaceutical Stock Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 600222 current and non-current assets.
Liquidity & Leverage Metrics
Henan Taloph Pharmaceutical Stock Co Ltd Total Liabilities Ratios Explained
Henan Taloph Pharmaceutical Stock Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.26 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.25 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.55 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Henan Taloph Pharmaceutical Stock Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Henan Taloph Pharmaceutical Stock Co Ltd (1996–2025)
The table below shows the annual total liabilities of Henan Taloph Pharmaceutical Stock Co Ltd from 1996 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥1.98 Billion ≈ $289.59 Million |
+6.20% |
| 2024-12-31 | CN¥1.86 Billion ≈ $272.69 Million |
-4.60% |
| 2023-12-31 | CN¥1.95 Billion ≈ $285.85 Million |
-1.64% |
| 2022-12-31 | CN¥1.99 Billion ≈ $290.63 Million |
-1.00% |
| 2021-12-31 | CN¥2.01 Billion ≈ $293.56 Million |
+7.93% |
| 2020-12-31 | CN¥1.86 Billion ≈ $272.00 Million |
+30.20% |
| 2019-12-31 | CN¥1.43 Billion ≈ $208.91 Million |
-1.14% |
| 2018-12-31 | CN¥1.44 Billion ≈ $211.32 Million |
+11.09% |
| 2017-12-31 | CN¥1.30 Billion ≈ $190.22 Million |
+12.95% |
| 2016-12-31 | CN¥1.15 Billion ≈ $168.41 Million |
+0.94% |
| 2015-12-31 | CN¥1.14 Billion ≈ $166.84 Million |
+3.13% |
| 2014-12-31 | CN¥1.11 Billion ≈ $161.78 Million |
+28.37% |
| 2013-12-31 | CN¥861.22 Million ≈ $126.02 Million |
-5.66% |
| 2012-12-31 | CN¥912.93 Million ≈ $133.59 Million |
+9.82% |
| 2011-12-31 | CN¥831.28 Million ≈ $121.64 Million |
+29.50% |
| 2010-12-31 | CN¥641.92 Million ≈ $93.93 Million |
+26.83% |
| 2009-12-31 | CN¥506.12 Million ≈ $74.06 Million |
+32.69% |
| 2008-12-31 | CN¥381.43 Million ≈ $55.82 Million |
+17.98% |
| 2007-12-31 | CN¥323.29 Million ≈ $47.31 Million |
+0.33% |
| 2006-12-31 | CN¥322.24 Million ≈ $47.15 Million |
+15.63% |
| 2005-12-31 | CN¥278.70 Million ≈ $40.78 Million |
-1.67% |
| 2004-12-31 | CN¥283.44 Million ≈ $41.48 Million |
+5.62% |
| 2003-12-31 | CN¥268.36 Million ≈ $39.27 Million |
+1.38% |
| 2002-12-31 | CN¥264.70 Million ≈ $38.73 Million |
+28.45% |
| 2001-12-31 | CN¥206.07 Million ≈ $30.15 Million |
+26.85% |
| 2000-12-31 | CN¥162.45 Million ≈ $23.77 Million |
+7.51% |
| 1999-12-31 | CN¥151.10 Million ≈ $22.11 Million |
-8.31% |
| 1998-12-31 | CN¥164.79 Million ≈ $24.11 Million |
+17.47% |
| 1997-12-31 | CN¥140.28 Million ≈ $20.53 Million |
+0.04% |
| 1996-12-31 | CN¥140.23 Million ≈ $20.52 Million |
-- |
About Henan Taloph Pharmaceutical Stock Co Ltd
Henan Taloph Pharmaceutical Stock Co.,Ltd engages in the research, development, and sale of pharmaceutical preparations and Chinese herbal medicines in China. Its principal products include Shuanghuanglian oral liquid series, Shuangjinlian mixture, pediatric Qingrezhike oral liquid, Huoxiangzhengqi mixture, Danshen and Wuzi Yanzong oral liquid, Shengmaiyin, pediatric compound chicken gizzard chew… Read more